Ping An HealthKonnect

Academician Pan Yi and Professor Shen Bairong joined the Weiwei science and technology strategy committee

Medtronic's world's first self expanding pulmonary valve was first-class recalled

Inactivated vaccine against novel coronavirus of Chinese medicine Zhongsheng Omicron mutant approved for clinical use

The new crown inactivated vaccine of Sinopharm Zhongsheng Omicron mutant was approved clinically.

Yanye said that its Xinguan oral drug s-217622 can quickly eliminate the virus

Bojian abandons Alzheimer's disease drug aduhelm and goes public in the EU

Upside foods, a cell meat enterprise, received US $400 million in financing, the highest single transaction in the industry

Lingfu biology, an experimental animal research service provider, completed a pre-A round of financing of more than 200 million yuan

Hefei Tiangang immunopharmaceutical Co., Ltd., a tumor immunotherapy enterprise, completed a round of pre-A financing of hundreds of millions of yuan

Ping An Health's 2021 annual report was released, with a revenue of 7.3 billion yuan, a year-on-year increase of 8%

"Tiandu technology" won tens of millions of yuan of seed round financing, and AI computing enabled the innovative drug industry

Representative Li Yanping: further improve medical services for the elderly and actively respond to the challenges of aging

The world's first pig heart transplant patient died two months after the operation, and the cause of death is not clear

Gan liming, former vice president of global R & D of AstraZeneca, became president and chief medical officer of global R & D of Ruibo biology

Benoda for car-t therapy of mingjunuo reported the new indication to the State Food and Drug Administration for listing